Biotech

All Articles

Novartis sparks brand new phase of Voyager deal with $15M capsid bargain

.Novartis levels a brand-new frontier in its own cooperation along with Voyager Therapeutics, spendi...

Lilly blog posts extra favorable records on its regular blood insulin prospect

.On the heels of an FDA rejection for its own main competing Novo Nordisk, Eli Lilly is gaining grou...

IN 8bio halts period 2 trial, gives up one-half of labor force

.Only a few months after dosing the very first person in a stage 2 test for freshly detected gliobla...

Lilly, Haya ink $1B biobuck excessive weight pact to look black genome

.Eli Lilly's search for excessive weight aim ats has actually led it to the darker genome. The Big P...

ArsenalBio increases $325M, turns away from former lead possession

.Collection Biosciences is actually proceeding up. The tissue treatment provider has actually added ...

Lilly- backed fat burning biotech files IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has submitted to...

Aelis' marijuana make use of medication flunks period 2b, driving Indivior to review $100M option

.Aelis Farma's hopes of getting a quick, good decision on a $one hundred million alternative settlem...

ProKidney stops phase 3 test not required for tissue treatment confirmation

.ProKidney has quit among a pair of phase 3 tests for its tissue therapy for kidney condition after ...

Vaxcyte climbs on 'sensational' 31-valent PCV win versus Pfizer

.Vaxcyte introduced what experts referred to as "remarkable" stage 1/2 data for its 31-valent pneumo...

Recursion's mind disease trial presents little evidence of effectiveness

.Recursion has actually discovered through an early test of its tech-enabled method to medicine reve...